These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8546572)

  • 1. Hepatitis C. A clinical update.
    Colquhoun SD
    Arch Surg; 1996 Jan; 131(1):18-23. PubMed ID: 8546572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.
    Tassopoulos NC; Hatzakis AE; Papatheodoridis GV; Karvountzis G; Troonen H; Lennartz L
    J Hepatol; 1994 Feb; 20(2):305-6. PubMed ID: 7516362
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing chronic hepatitis C virus infection.
    Lau JY; Davis GL
    BMJ; 1993 Feb; 306(6876):469-70. PubMed ID: 7680588
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-A, non-B hepatitis: impact of the emergence of the hepatitis C virus.
    Hsia PC; Seeff LB
    Adv Intern Med; 1992; 37():197-222. PubMed ID: 1313633
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C.
    Morton TA; Kelen GD
    Ann Emerg Med; 1998 Mar; 31(3):381-90. PubMed ID: 9506498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of early interferon alfa therapy for hepatitis C virus infection recurrence after liver transplantation.
    Boillot O; Berger F; Rasolofo E; Mion F; Chevallier P; Gille D; Paliard P
    Transplant Proc; 1995 Aug; 27(4):2501. PubMed ID: 7544508
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C virus. What recent studies can tell us.
    Dana F; Becherer PR; Bacon BR
    Postgrad Med; 1994 May; 95(6):121-2, 125-30. PubMed ID: 8170870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis.
    Yokosuka O; Ito Y; Imazeki F; Ohto M; Omata M
    Biochem Biophys Res Commun; 1992 Nov; 189(1):565-71. PubMed ID: 1280430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.
    Genesca J; Esteban JI; Quer J; Viladomiu LL; Gonzalez A; Esteban R; Guardia J
    Gut; 1993; 34(2 Suppl):S62-3. PubMed ID: 7686120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Viral hepatitis C].
    Zeuzem S; Roth WK; Herrmann G
    Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current aspects of hepatitis C].
    Henry JP; Hayard P; Hayani A; Ligny G
    Rev Med Brux; 1994; 15(4):211-5. PubMed ID: 7524123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus--epidemiology and serological diagnosis.
    Skidmore S
    J Med Microbiol; 1993 Nov; 39(5):321-2. PubMed ID: 7504111
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C virus RNA and anti-N14 antibody levels during interferon alpha therapy for chronic hepatitis C.
    Oketani M; Tanaka K; Sho Y; Maeda E; Miyazaki H; Arima T
    Intern Med; 1994 Oct; 33(10):588-92. PubMed ID: 7530068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients.
    Pol S; Thiers V; Carnot F; Zins B; Roméo R; Berthelot P; Bréchot C
    Nephrol Dial Transplant; 1996; 11 Suppl 4():58-61. PubMed ID: 8918758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.